<I wouldn't have dumped a million bucks into progenetics. Think about the associated dilution relative to this last placement 1 million dollars amounts to. I wouldn't have bought back shares from genzyme a few years ago for ten million.>
I do agree with you. The progenetics deal should have been delayed until a US partnership for ATIII was in place. I also wasn't pleased with the GENZ. These are management failures or at least management disregard for current shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.